SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-19-003324
Filing Date
2019-02-20
Accepted
2019-02-19 18:25:05
Documents
101
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rare-10k_20181231.htm 10-K 3958008
2 EX-10.66 rare-ex1066_2833.htm EX-10.66 85665
3 EX-21.1 rare-ex211_25.htm EX-21.1 14325
4 EX-23.1 rare-ex231_12.htm EX-23.1 5356
5 EX-31.1 rare-ex311_28.htm EX-31.1 17195
6 EX-31.2 rare-ex312_24.htm EX-31.2 17195
7 EX-32.1 rare-ex321_16.htm EX-32.1 9167
8 GRAPHIC gswyiezahwgz000002.jpg GRAPHIC 16996
9 GRAPHIC gswyiezahwgz000001.jpg GRAPHIC 41780
  Complete submission text file 0001564590-19-003324.txt   12987072

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT rare-20181231.xml EX-101.INS 2839762
11 XBRL TAXONOMY EXTENSION SCHEMA rare-20181231.xsd EX-101.SCH 80786
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rare-20181231_cal.xml EX-101.CAL 88038
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rare-20181231_def.xml EX-101.DEF 266757
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE rare-20181231_lab.xml EX-101.LAB 598879
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rare-20181231_pre.xml EX-101.PRE 489890
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36276 | Film No.: 19616512
SIC: 2834 Pharmaceutical Preparations